Bivalirudin resistance during heart transplantation surgery.
Introduction: : Direct thrombin inhibitors are drugs of choice used to prevent thrombotic complications in hospitalized patients after heparin induced thrombocytopenia (HIT) diagnosis. Material and method: : We present a case of bivalirudin resistance in patient undergoing heart transplantation due...
Main Authors: | Tomasz Urbanowicz, Anna Olasińska-Wiśniewska, Marcin Ligowski, Ewa Goszczyńska, Marek Jemielity |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Transplantation Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451959620300330 |
Similar Items
-
Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01) -
Is it time to switch to bivalirudin for ECMO anticoagulation?
by: Amir Navaei, et al.
Published: (2023-08-01) -
Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
by: Emre Boysan, et al.
Published: (2023-09-01) -
New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
by: María Asunción Esteve-Pastor, et al.
Published: (2016-02-01) -
Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses
by: Mikael Lund, et al.
Published: (2021-09-01)